United States · FDA National Drug Code directory
Atazanavir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42385-922_0e18774c-a32c-4961-9684-f5c6ffce64a1
- Product NDC
- 42385-922
- Form
- CAPSULE
- Composition / generic term
- Atazanavir
- Labeler
- Laurus Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210430
- Source listing expiry
- 20261231
Source-listed ingredients
- ATAZANAVIR SULFATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (42385-922-30) · 42385-922-30
- 5 BLISTER PACK in 1 CARTON (42385-922-37) / 6 CAPSULE in 1 BLISTER PACK (42385-922-06) · 42385-922-37
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →